Loading company…
SHENGRUIZEHUA develops and produces small-molecule drugs, including molecular glue drug candidates.
SHENGRUIZEHUA works on medical research, biochemical technology, and small-molecule drug development. Established in 2022, it is based in Suzhou, China, and raised angel funding from Kaitai Capital in July 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in